Phillips 66 (PSX) Shares Rose While Aristotle Capital Management Has Upped Holding; America First Investment Advisors Position in Abbott Laboratories (ABT) Lowered as Market Valuation Rose

Abbott Laboratories (NYSE:ABT) Logo

Aristotle Capital Management Llc increased its stake in Phillips 66 (PSX) by 1.73% based on its latest 2019Q1 regulatory filing with the SEC. Aristotle Capital Management Llc bought 74,304 shares as the company’s stock rose 11.67% . The institutional investor held 4.36M shares of the integrated oil company at the end of 2019Q1, valued at $415.41M, up from 4.29 million at the end of the previous reported quarter. Aristotle Capital Management Llc who had been investing in Phillips 66 for a number of months, seems to be bullish on the $43.72 billion market cap company. The stock decreased 0.06% or $0.06 during the last trading session, reaching $97.47. About 2.07 million shares traded. Phillips 66 (NYSE:PSX) has declined 16.04% since August 16, 2018 and is downtrending. It has underperformed by 16.04% the S&P500. Some Historical PSX News: 13/03/2018 – PHILLIPS 66 PSX.N : CITIGROUP RAISES TARGET PRICE TO $94 FROM $92; 27/04/2018 – PHILLIPS 66 GARLAND: DON’T HOLD A LOT OF HOPE FOR RINS REFORM; 27/04/2018 – Phillips 66 1Q Adj EPS $1.04; 19/04/2018 – Phillips 66 Rises for 9 Days; Longest Winning Streak in 6 Years; 09/04/2018 – Mastercard and Phillips 66 Drive Easier Payments with Masterpass; 27/04/2018 – PHILLIPS 66 – EARNINGS REFLECT BENEFIT OF DIVERSIFIED PORTFOLIO, AND ARE ALSO SEEING POSITIVE, ONGOING IMPACTS FROM U.S. TAX REFORM; 27/04/2018 – PHILLIPS 66 CONCLUDES 1Q EARNINGS CONFERENCE CALL; 25/05/2018 – Subtropical storm Alberto’s landfall expected early next week; 23/04/2018 – Phillips 66 Reports Emissions at Borger, Texas, Refinery; 02/04/2018 – PHILLIPS 66 ALLIANCE LOUISIANA REFINERY RESTARTS HYDROTREATER

America First Investment Advisors Llc decreased its stake in Abbott Laboratories (ABT) by 4.03% based on its latest 2019Q1 regulatory filing with the SEC. America First Investment Advisors Llc sold 9,524 shares as the company’s stock rose 10.62% . The institutional investor held 226,729 shares of the major pharmaceuticals company at the end of 2019Q1, valued at $18.13 million, down from 236,253 at the end of the previous reported quarter. America First Investment Advisors Llc who had been investing in Abbott Laboratories for a number of months, seems to be less bullish one the $148.36 billion market cap company. It closed at $83.94 lastly. It is down 33.65% since August 16, 2018 and is uptrending. It has outperformed by 33.65% the S&P500. Some Historical ABT News: 18/05/2018 – ABBOTT: THERE ARE 1 OR 2 OTHER PEOPLE OF INTEREST; 05/04/2018 – FDA: Abbott Perclose ProGlide Suture-Mediated Closure System – P960043/S097; 03/04/2018 – Johnson Controls appoints Nancy Berce as chief information officer; 06/03/2018 – U.S. FDA SAYS GRANTED APPROVAL OF MASTER SERIES HEART VALVE TO ST JUDE MEDICAL; 28/03/2018 – ASAHI Receives CTO lndication for Corsair and Coronary Guide Wires; 17/04/2018 – Investor Expectations to Drive Momentum within Bank of America, Abbott Laboratories, Analog Devices, Mohawk Industries, Maxwell; 23/03/2018 – Abbott’s Alere resolves US diagnostic device probe for $33.2 million; 18/05/2018 – ABBOTT SAYS LAW ENFORCEMENT STILL SEARCHING, INVESTIGATING ENTIRE SCENE, LOOKING AT TWO RESIDENCES; 16/03/2018 – Drug Makers use Nanotechnology to Improve Delivery and Dosing; 18/04/2018 – ABBOTT 1Q EARNINGS CALL ENDS

More notable recent Abbott Laboratories (NYSE:ABT) news were published by: which released: “With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF – Benzinga” on July 23, 2019, also with their article: “Abbott recalls certain Ellipse ICDs – Seeking Alpha” published on August 05, 2019, published: “Abbott Laboratories (ABT) Q2 2019 Earnings Call Transcript – Yahoo Finance” on July 17, 2019. More interesting news about Abbott Laboratories (NYSE:ABT) were released by: and their article: “Is Abbott Laboratories (NYSE:ABT) Investing Your Capital Efficiently? – Yahoo Finance” published on July 02, 2019 as well as‘s news article titled: “Should Abbott Laboratories (NYSE:ABT) Be Part Of Your Dividend Portfolio? – Yahoo Finance” with publication date: May 18, 2019.

Investors sentiment decreased to 0.82 in Q1 2019. Its down 0.09, from 0.91 in 2018Q4. It dropped, as 52 investors sold ABT shares while 617 reduced holdings. 143 funds opened positions while 408 raised stakes. 1.26 billion shares or 2.74% less from 1.29 billion shares in 2018Q4 were reported. Fire Grp holds 6.39% or 215,000 shares in its portfolio. 54,301 were reported by Cwm Ltd Com. Parsec Mngmt Incorporated has invested 1.19% of its portfolio in Abbott Laboratories (NYSE:ABT). Leisure Cap Management stated it has 0.78% of its portfolio in Abbott Laboratories (NYSE:ABT). Kcm Ltd Com has 1% invested in Abbott Laboratories (NYSE:ABT) for 192,535 shares. Private Wealth Advisors reported 10,726 shares or 0.32% of all its holdings. Oakworth Cap Inc stated it has 11,540 shares or 0.19% of all its holdings. Hillsdale Investment Mngmt Inc has 760 shares. Culbertson A N & Comm Incorporated holds 2.54% or 110,382 shares. Oxbow Ltd owns 7,586 shares. California-based Capital World has invested 0% in Abbott Laboratories (NYSE:ABT). Tiaa Cref Management Lc reported 0.48% stake. Beacon Management Inc holds 475 shares or 0% of its portfolio. Mountain Pacific Invest Advisers Id holds 0.25% or 33,251 shares. Cap Advsrs Ltd Limited Liability holds 0.05% of its portfolio in Abbott Laboratories (NYSE:ABT) for 2,238 shares.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on October, 16. They expect $0.84 earnings per share, up 12.00% or $0.09 from last year’s $0.75 per share. ABT’s profit will be $1.48 billion for 24.98 P/E if the $0.84 EPS becomes a reality. After $0.82 actual earnings per share reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 2.44% EPS growth.

America First Investment Advisors Llc, which manages about $259.46 million and $326.07 million US Long portfolio, upped its stake in Schlumberger Ltd (NYSE:SLB) by 19,125 shares to 248,136 shares, valued at $10.81M in 2019Q1, according to the filing.

Aristotle Capital Management Llc, which manages about $7.10 billion and $16.83 billion US Long portfolio, decreased its stake in Ishares Tr (EFA) by 200,976 shares to 43,056 shares, valued at $2.79 million in 2019Q1, according to the filing. It also reduced its holding in Kroger Co (NYSE:KR) by 3.90M shares in the quarter, leaving it with 7.09 million shares, and cut its stake in Ansys Inc (NASDAQ:ANSS).

Investors sentiment increased to 1.21 in Q1 2019. Its up 0.12, from 1.09 in 2018Q4. It is positive, as 39 investors sold PSX shares while 350 reduced holdings. 111 funds opened positions while 358 raised stakes. 305.73 million shares or 2.08% less from 312.21 million shares in 2018Q4 were reported. Kayne Anderson Advisors Lp invested in 300,700 shares. Sentinel Tru Comm Lba stated it has 2,374 shares. Moreover, Kemnay Advisory Svcs Incorporated has 0.14% invested in Phillips 66 (NYSE:PSX). Orleans Capital Corporation La accumulated 0.72% or 9,900 shares. Acg Wealth invested 0.03% of its portfolio in Phillips 66 (NYSE:PSX). 79,671 were accumulated by Oppenheimer Asset. Gamble Jones Investment Counsel invested in 0.06% or 7,712 shares. Hartford Financial Mgmt, a Connecticut-based fund reported 13,977 shares. Rnc Management reported 2.53% stake. Moreover, Amica Retiree Medical has 0.2% invested in Phillips 66 (NYSE:PSX) for 2,346 shares. California-based Financial Advisers Ltd Company has invested 0.14% in Phillips 66 (NYSE:PSX). Highstreet Asset Mngmt reported 0.06% of its portfolio in Phillips 66 (NYSE:PSX). 169,247 were reported by Group. Osborne Prtnrs Cap Limited holds 1.34% or 71,965 shares in its portfolio. Harvest Cap Mngmt reported 2,274 shares stake.

Since May 28, 2019, it had 1 insider buy, and 0 sales for $165,816 activity.

Phillips 66 (NYSE:PSX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.